Company Provides New 2016 Guidance

LAVAL, Quebec, March 15, 2016 /CNW/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (the “Company”) today announced preliminary unaudited financial information for the fourth quarter 2015.

As a result of the ongoing work…